Nurotron develops implantable neuro-electronic devices in Hangzhou, China, including cochlear implants and sacral nerve stimulators.
Founded in 2006 and based in Hangzhou, China, Zhejiang Nurotron Biotechnology Co., Ltd., trading as Nurotron, develops implantable neuro-electronic medical devices. Its portfolio includes cochlear implant systems, auditory brainstem implant systems, artificial vision prosthetics and sacral nerve stimulation systems. The company was twice awarded the National Science and Technology Progress Award (2015, 2024). In May 2025 it received an investment from Hangzhou Capital Investment and Yuhang Jinkong to strengthen its global presence.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in